Sireesh Appajosyula - 23 Oct 2026 Form 4 Insider Report for Hepion Pharmaceuticals, Inc. (HEPA)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: HEPA
Reported as of: 23 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Oct 2026, 16:30:34 UTC
Prior SEC filing: 21 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Sireesh Appajosyula

Filing notes and source

Key filing fact

Sireesh Appajosyula filed Form 4 for Hepion Pharmaceuticals, Inc. (HEPA) on 27 Oct 2026.

Key facts

This page summarizes Sireesh Appajosyula's Form 4 filing for Hepion Pharmaceuticals, Inc. (HEPA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 27 Oct 2026, 16:30.

Change

Previous filing in this sequence was filed on 21 Aug 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001901565 Primary reporting owner

Appajosyula Sireesh

Relationship: Chief Executive Officer, Director
Address: C/O HEPION PHARMACEUTICALS, INC., 22 WEST ST., SUITE 1B, RED BANK
Signature: /s/ Sireesh Appajosyula
Signature date: 27 Oct 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HEPA transaction Derivative

Stock Options

Award

Transaction value
Shares: +1,530,000
Change %: +114%
Price: $0.000000^*
Shares after: 2,875,500
Date: 23 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,530,000
Exercise price: $0.1400
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

127,500 options vest in equal amounts monthly over 12 months from date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .